Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;44(9):3287-3290.
doi: 10.1007/s10072-023-06882-x. Epub 2023 Jun 7.

Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer's disease

Federico Verde  1   2 , Ilaria Milone  3 , Antonella Dubini  4 , Claudia Colombrita  4 , Alberto Perego  5 , Federica Solca  3 , Alessio Maranzano  3 , Emilio Ciusani  6 , Barbara Poletti  3   7 , Antonia Ratti  3   8 , Erminio Torresani  4 , Vincenzo Silani  3   9 , Nicola Ticozzi  3   9
Affiliations

Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer's disease

Federico Verde et al. Neurol Sci. 2023 Sep.

Abstract

Introduction: Alzheimer's disease (AD) is characterized by decreased cerebrospinal fluid (CSF) Aβ42 and Aβ42/Aβ40 ratio. Aβ peptides can now be measured also in plasma and are promising peripheral biomarkers for AD. We evaluated the relationships of plasma Aβ species with their CSF counterparts, kidney function, and serum/CSF albumin ratio (Q-Alb) in AD patients.

Materials and methods: We measured plasma Aβ42 and Aβ40, as well as CSF AD biomarkers, with the fully automated Lumipulse platform in a cohort of N = 30 patients with clinical and neurochemical diagnosis of AD.

Results: The two plasma Aβ peptides correlated strongly with each other (r = 0.7449), as did the corresponding CSF biomarkers (r = 0.7670). On the contrary, the positive correlations of plasma Aβ42, Aβ40, and Aβ42/Aβ40 ratio with their CSF counterparts and the negative correlation of plasma Aβ42/Aβ40 ratio with CSF P-tau181 were not statistically significant. Plasma levels of both Aβ species negatively correlated with estimated glomerular filtration rate (eGFR) (Aβ42: r = -0.4138; Aβ40: r = -0.6015), but plasma Aβ42/Aβ40 ratio did not. Q-Alb did not correlate with any plasma Aβ parameter.

Discussion: Plasma Aβ42 and Aβ40 are critically influenced by kidney function; however, their ratio is advantageously spared from this effect. The lack of significant correlations between plasma Aβ species and their CSF counterparts is probably mainly due to small sample size and inclusion of only Aβ + individuals. Q-Alb is not a major determinant of plasma Aβ concentrations, highlighting the uncertainties about mechanisms of Aβ transfer between CNS and periphery.

Keywords: Alzheimer’s disease (AD); Amyloid; Aβ40; Aβ42; Biomarkers; Plasma.

PubMed Disclaimer

References

    1. Brand AL, Lawler PE, Bollinger JG et al (2022) The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review. Alzheimers Res Ther 14(1):195. https://doi.org/10.1186/s13195-022-01117-1 - DOI - PubMed - PMC
    1. Musso G, Cosma C, Zaninotto M, Gabelli C, Basso D, Plebani M (2023) Pre-analytical variability of the Lumipulse immunoassay for plasma biomarkers of Alzheimer's disease. Clin Chem Lab Med 61(3):e53–e56. https://doi.org/10.1515/cclm-2022-0770 - DOI - PubMed
    1. Stocker H, Beyer L, Trares K, et al. Association of kidney function with development of Alzheimer disease and other dementias and dementia-related blood biomarkers. JAMA Netw Open. Jan 3 2023;6(1):e2252387. https://doi.org/10.1001/jamanetworkopen.2022.52387
    1. Lehmann S, Schraen-Maschke S, Vidal JS et al (2023) Plasma Abeta42/Abeta40 ratio is independent of renal function. Alzheimers Dement. https://doi.org/10.1002/alz.12949
    1. Giacopuzzi Grigoli E, Solca F, Milone I et al (2023) Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients. Neurol Sci 44(2):709–713. https://doi.org/10.1007/s10072-022-06530-w - DOI - PubMed

LinkOut - more resources